Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Parmentier

Showing results (191-200 of 213) with videos related to

Pageof 22
Sort By:
European Journal of Immunology|May 29, 1998
ChemR23, a putative chemoattractant receptor, is expressed in monocyte-derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strainsM Samson, A L Edinger, P Stordeur, et al.
The Journal of Biological Chemistry|June 26, 1999
Extracellular cysteines of CCR5 are required for chemokine binding, but dispensable for HIV-1 coreceptor activityC Blanpain, B Lee, J Vakili, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1985
Biochemical studies of rat atrial natriuretic factorT Inagami, K S Misono, R T Grammer, et al.
Rheumatology (Oxford, England)|August 25, 2023
Differential properties of Janus kinase inhibitors in the treatment of immune-mediated inflammatory diseasesPeter C Taylor, Ernest Choy, Xenofon Baraliakos, et al.
Nature|August 14, 1997
Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptorC Ledent, J M Vaugeois, S N Schiffmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 14, 1999
CD26/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3S Struyf, P Proost, D Schols, et al.
The Journal of Biological Chemistry|February 7, 1998
The CC chemokine I-309 inhibits CCR8-dependent infection by diverse HIV-1 strainsR Horuk, J Hesselgesser, Y Zhou, et al.
The Journal of Experimental Medicine|October 23, 1997
Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine bindingL Wu, G LaRosa, N Kassam, et al.
The Journal of Biological Chemistry|April 27, 2001
Palmitoylation of CCR5 is critical for receptor trafficking and efficient activation of intracellular signaling pathwaysC Blanpain, V Wittamer, J M Vanderwinden, et al.
The Journal of Biological Chemistry|November 27, 1999
Multiple charged and aromatic residues in CCR5 amino-terminal domain are involved in high affinity binding of both chemokines and HIV-1 Env proteinC Blanpain, B J Doranz, J Vakili, et al.
Pageof 22

Showing results (191-200 of 213) with videos related to

Sort By:
Pageof 22
European Journal of Immunology|May 29, 1998
ChemR23, a putative chemoattractant receptor, is expressed in monocyte-derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strainsM Samson, A L Edinger, P Stordeur, et al.
The Journal of Biological Chemistry|June 26, 1999
Extracellular cysteines of CCR5 are required for chemokine binding, but dispensable for HIV-1 coreceptor activityC Blanpain, B Lee, J Vakili, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1985
Biochemical studies of rat atrial natriuretic factorT Inagami, K S Misono, R T Grammer, et al.
Rheumatology (Oxford, England)|August 25, 2023
Differential properties of Janus kinase inhibitors in the treatment of immune-mediated inflammatory diseasesPeter C Taylor, Ernest Choy, Xenofon Baraliakos, et al.
Nature|August 14, 1997
Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptorC Ledent, J M Vaugeois, S N Schiffmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 14, 1999
CD26/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3S Struyf, P Proost, D Schols, et al.
The Journal of Biological Chemistry|February 7, 1998
The CC chemokine I-309 inhibits CCR8-dependent infection by diverse HIV-1 strainsR Horuk, J Hesselgesser, Y Zhou, et al.
The Journal of Experimental Medicine|October 23, 1997
Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine bindingL Wu, G LaRosa, N Kassam, et al.
The Journal of Biological Chemistry|April 27, 2001
Palmitoylation of CCR5 is critical for receptor trafficking and efficient activation of intracellular signaling pathwaysC Blanpain, V Wittamer, J M Vanderwinden, et al.
The Journal of Biological Chemistry|November 27, 1999
Multiple charged and aromatic residues in CCR5 amino-terminal domain are involved in high affinity binding of both chemokines and HIV-1 Env proteinC Blanpain, B J Doranz, J Vakili, et al.
Pageof 22